Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model-Reference-Cited by-同舟云学术

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model

Published:2021-02 Issue:2 Volume:24 Page:102054
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Mohandas Sreelekshmy,Yadav Pragya D.^ORCID,Shete-Aich Anita,Abraham Priya,Vadrevu Krishna Mohan,Sapkal Gajanan,Mote Chandrashekhar,Nyayanit Dimpal,Gupta Nivedita,Srinivas Vellimedu Kannappa,Kadam Manoj,Kumar Abhimanyu,Majumdar Triparna^ORCID,Jain Rajlaxmi,Deshpande Gururaj,Patil Savita,Sarkale Prasad,Patil Deepak,Ella Raches,Prasad Sai D.,Sharma Sharda,Ella Krishna M.,Panda Samiran,Bhargava Balram

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference33 articles.

1. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate;Addetia;J. Clin. Microbiol.,2020

2. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility;Chan;Clin. Infect. Dis. Mar.,2020

3. Parenteral vaccination can be an effective means of inducing protective mucosal responses;Clements;Clin. Vaccin. Immunol.,2016

4. A new threat from an old enemy: Re-emergence of coronavirus;Docea;Int. J. Mol. Med.,2020

5. Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine-Bbv152;Ganneru,2020

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals;Scientific Reports;2024-07-24

2. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine;Scientific Reports;2024-02-20

3. Exploring the promise of COVID-19 vaccines: A review of preclinical studies;Features, Transmission, Detection, and Case Studies in COVID-19;2024

4. Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination;Monaldi Archives for Chest Disease;2023-12-01

5. Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters;Frontiers in Microbiology;2023-06-22